GSK PLC (LSE:GSK)
£ 18.1 0.105 (0.58%) Market Cap: 73.81 Bil Enterprise Value: 87.49 Bil PE Ratio: 17.87 PB Ratio: 5.33 GF Score: 77/100

GlaxoSmithKline PLC Investor Update Transcript

Jun 23, 2021 / 01:00PM GMT
Release Date Price: £14.2 (+1.03%)
Iain James Mackay
GlaxoSmithKline plc - CFO & Executive Director

Good morning and good afternoon. I'm Iain Mackay, CFO of GSK. And it's my pleasure to welcome you to our investor update.

We have a packed agenda, which I'll detail in just a minute.

However, before I do that, I'd like to mention a couple of housekeeping details. First, you should have received our press release and you can view the presentation on GSK's website. For those not able to view the webcast, the slides that accompany today's event are located on the investor section of the GSK website. Second, during the question-and-answer session, we would ask that you limit your questions to 2 so that everyone has the chance to participate.

Before I begin, please refer to Slide 2 of our presentation for our cautionary statements, and our basis of preparation can be found in the appendix. And with that, we'll move to Slide 3, and let me take you briefly through our agenda.

Our speakers today are Emma Walmsley, Luke Miels, Dr. Hal Barron, Deborah Waterhouse, Dr. Kimberly Smith and myself, and Roger

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot